Gilead Sciences
GILD
#129
Rank
S$194.99 B
Marketcap
S$157.15
Share price
-1.14%
Change (1 day)
28.57%
Change (1 year)

Gilead Sciences (GILD) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$48.06 Billion

According to Gilead Sciences's latest financial reports the company's total liabilities are S$48.06 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Gilead Sciences - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$54.02 B3.9%
2023-12-31S$52.00 B-7.56%
2022-12-31S$56.25 B-11.25%
2021-12-31S$63.38 B-4.53%
2020-12-31S$66.39 B26.35%
2019-12-31S$52.54 B-8.72%
2018-12-31S$57.57 B-13.54%
2017-12-31S$66.58 B22.31%
2016-12-31S$54.43 B18.04%
2015-12-31S$46.11 B85.21%
2014-12-31S$24.90 B81.41%
2013-12-31S$13.72 B-4.03%
2012-12-31S$14.30 B5.83%
2011-12-31S$13.51 B91.78%
2010-12-31S$7.04 B57.19%
2009-12-31S$4.48 B26.85%
2008-12-31S$3.53 B9.91%
2007-12-31S$3.21 B-5.43%
2006-12-31S$3.39 B176.48%
2005-12-31S$1.22 B164.39%
2004-12-31S$0.46 B-50.39%
2003-12-31S$0.93 B-24.63%
2002-12-31S$1.24 B96.26%
2001-12-31S$0.63 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
S$104.39 B 117.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$9.77 B-79.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$176.96 B 268.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$4.92 B-89.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$14.26 B-70.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$149.91 B 211.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$147.19 B 206.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$118.08 B 145.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$100.65 B 109.40%๐Ÿ‡บ๐Ÿ‡ธ USA